Mylan Tender For Perrigo Heavy With Drama, Light On Analyst Support
This article was originally published in The Tan Sheet
Executive Summary
Perrigo is stronger and has a more promising future on its own, analysts wrote in research notes published after 51% of Mylan’s shares on Aug. 28 were voted in approval of tendering an offer and before Sept. 14, when the tender was made to Perrigo shareholders.
You may also be interested in...
US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector
Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
US Senate Passes First Monograph Reform Bill After House Passed Three
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: